Empagliflozin
For Type 2 Diabetes & Heart Failure
The SGLT2 inhibitor that proved the class.
In brief…
Empagliflozin (Jardiance) was the first SGLT2 inhibitor to demonstrate a major reduction in cardiovascular death in the landmark EMPA-REG OUTCOME trial. It shares the class benefits of blood sugar lowering, weight loss, and heart and kidney protection. A once-daily tablet that does much more than control glucose.
Empagliflozin
For Type 2 Diabetes & Heart Failure
Strength
£20.99 (28 tablets) per pack· same price all strengths
Delivery
In post tomorrow. Tracked delivery, arrives in two working days.
What you need to know
Safety information
Driving & machinery
If you take gliclazide or insulin: risk of hypoglycaemia which can impair driving. Check blood glucose before driving. Carry glucose in the car.
Age restriction
Adults 18 and over for most agents. Metformin licensed from age 10 for type 2 diabetes.
Storage
Store below 25°C in a dry place. Keep out of reach and sight of children. Do not use after the expiry date.
We're here to help
Not sure if this is right for you? Book a consultation. Online or in-person.
Report side effects
If you experience any side effects, report them via the MHRA Yellow Card Scheme or call 0800 731 6789.
Regulatory information
LoveMyLife Pharmacy is GPhC registered. View our regulatory information · Complaints procedure
Looking for something else?